Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
16.94
-0.40 (-2.31%)
Jun 8, 2026, 12:51 PM EDT - Market open
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.5 billion as of June 8, 2026. Its market cap has increased by 63.80% in one year.
Market Cap
1.50B
Enterprise Value
1.50B
1-Year Change
63.80%
Ranking
Category
Stock Price
$16.94
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.50B, an increase of 619.58%. That is a compound annual growth rate of 21.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.54B | -15.86% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sionna Therapeutics | 1.60B |
| Tyra Biosciences | 1.58B |
| Taysha Gene Therapies | 1.58B |
| Novavax | 1.56B |
| Palvella Therapeutics | 1.56B |
| Capricor Therapeutics | 1.55B |
| SELLAS Life Sciences Group | 1.53B |
| Fortrea Holdings | 1.52B |